Cyclic nucleotide analogs as carcinostatic agents

G. A. LePage, Evan M Hersh

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Three cylcic nucleotide analogs, cyclic 3′,5′-arabinosyladenine monophosphate, cyclic 3′,5′-ribofuranosyl-6-mercaptopurine monophosphate and cyclic 3′,5′-ribofuranosyl-6-methylmercaptopurine monophosphate were tested for ability to penetrate murine tumor cells and human lymphocytes. Tests based on either tumor inhibition or inhibition of DNA synthesis in human lymphocytes undergoing blastogenesis, or both, indicated that these agents penetrated intact cells. It was demonstrated in one case (cAraMP) that the cells could convert the cyclic 3′,5′ nucleoside to 5′-nucleotide and that this had to occur intracellularly.

Original languageEnglish (US)
Pages (from-to)1918-1922
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume46
Issue number5
DOIs
StatePublished - Mar 10 1972
Externally publishedYes

Fingerprint

Lymphocytes
Cyclic Nucleotides
Tumors
Nucleotides
Vidarabine
6-Mercaptopurine
Nucleosides
Cells
Lymphocyte Activation
DNA
Neoplasms
6-methylthiopurine

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Cyclic nucleotide analogs as carcinostatic agents. / LePage, G. A.; Hersh, Evan M.

In: Biochemical and Biophysical Research Communications, Vol. 46, No. 5, 10.03.1972, p. 1918-1922.

Research output: Contribution to journalArticle

@article{0ab3ef5a78d04eeea824602b045c66e9,
title = "Cyclic nucleotide analogs as carcinostatic agents",
abstract = "Three cylcic nucleotide analogs, cyclic 3′,5′-arabinosyladenine monophosphate, cyclic 3′,5′-ribofuranosyl-6-mercaptopurine monophosphate and cyclic 3′,5′-ribofuranosyl-6-methylmercaptopurine monophosphate were tested for ability to penetrate murine tumor cells and human lymphocytes. Tests based on either tumor inhibition or inhibition of DNA synthesis in human lymphocytes undergoing blastogenesis, or both, indicated that these agents penetrated intact cells. It was demonstrated in one case (cAraMP) that the cells could convert the cyclic 3′,5′ nucleoside to 5′-nucleotide and that this had to occur intracellularly.",
author = "LePage, {G. A.} and Hersh, {Evan M}",
year = "1972",
month = "3",
day = "10",
doi = "10.1016/0006-291X(72)90070-8",
language = "English (US)",
volume = "46",
pages = "1918--1922",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "5",

}

TY - JOUR

T1 - Cyclic nucleotide analogs as carcinostatic agents

AU - LePage, G. A.

AU - Hersh, Evan M

PY - 1972/3/10

Y1 - 1972/3/10

N2 - Three cylcic nucleotide analogs, cyclic 3′,5′-arabinosyladenine monophosphate, cyclic 3′,5′-ribofuranosyl-6-mercaptopurine monophosphate and cyclic 3′,5′-ribofuranosyl-6-methylmercaptopurine monophosphate were tested for ability to penetrate murine tumor cells and human lymphocytes. Tests based on either tumor inhibition or inhibition of DNA synthesis in human lymphocytes undergoing blastogenesis, or both, indicated that these agents penetrated intact cells. It was demonstrated in one case (cAraMP) that the cells could convert the cyclic 3′,5′ nucleoside to 5′-nucleotide and that this had to occur intracellularly.

AB - Three cylcic nucleotide analogs, cyclic 3′,5′-arabinosyladenine monophosphate, cyclic 3′,5′-ribofuranosyl-6-mercaptopurine monophosphate and cyclic 3′,5′-ribofuranosyl-6-methylmercaptopurine monophosphate were tested for ability to penetrate murine tumor cells and human lymphocytes. Tests based on either tumor inhibition or inhibition of DNA synthesis in human lymphocytes undergoing blastogenesis, or both, indicated that these agents penetrated intact cells. It was demonstrated in one case (cAraMP) that the cells could convert the cyclic 3′,5′ nucleoside to 5′-nucleotide and that this had to occur intracellularly.

UR - http://www.scopus.com/inward/record.url?scp=0015500598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015500598&partnerID=8YFLogxK

U2 - 10.1016/0006-291X(72)90070-8

DO - 10.1016/0006-291X(72)90070-8

M3 - Article

C2 - 5015235

AN - SCOPUS:0015500598

VL - 46

SP - 1918

EP - 1922

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 5

ER -